X0304 4 2011-08-08 0 0001338042 Aegerion Pharmaceuticals, Inc. AEGR 0001257444 ALTA BIOPHARMA PARTNERS III LP ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001198332 PENHOET EDWARD ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001198321 CHAMPSI FARAH ONE EMBARCADERO CENTER SUITE 4050 SAN FRANCISCO CA 94132 0 0 1 0 0001211840 HURWITZ EDWARD ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001280234 ALTA BIOPHARMA MANAGEMENT III LLC ONE EMBARCADERO CENTER, SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001280265 ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 0001280238 ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111 0 0 1 0 Common Stock 2455167 D Common Stock 2011-08-08 4 P 0 3847 12.4296 A 2459014 D Common Stock 2011-08-09 4 P 0 5038 12.454 A 2464052 D Common Stock 164882 D Common Stock 2011-08-08 4 P 0 258 12.4296 A 165140 D Common Stock 2011-08-09 4 P 0 338 12.454 A 165478 D Common Stock 60502 D Common Stock 2011-08-08 4 P 0 95 12.4296 A 60597 D Common Stock 2011-08-09 4 P 0 124 12.454 A 60721 D These securities are beneficially own by Alta BioPharma Partners III, L.P. ("ABPIII"). Alta BioPharma Management III, LLC ("ABMIII") is the general Partner of ABPIII, the managing limited partner of Alta BioPharma Partners III GmbH & Co. Beteiligungs KG ("ABPIIIKG"). Farah Champsi, Edward Penhoet, and Edward Hurwitz are directors of ABMIII and managers of Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII"), along with ABPIII and ABPIIIKG shall be known as "the Funds," exercise shared voting and investment power with respect to the securities held by the funds. Alison Kiley, a director of the Issuer, is a member of ABMIII. She does not have sole or shared voting power over the shares owned by ABPIII, ABPIIIKG, and AEBPIII. Each of the reporting persons disclaim beneficial ownership of such securities, except to the extend of his, her, or its proportionate pecuniary interest herein. On August 8, 2011, ABPIII, ABMPIIIKG, and AEBPIII acquired 3847, 258, and 95 shares of the Issuer's Common Stock, respectively, from the public market at an average price of $12.4296 per share. On August 9, 2011, ABPIII, ABMPIIIKG, and AEBPIII acquired 5038, 338, and 124 shares of the Issuer's Common Stock, respectively, from the public market at an average price of $12.454 per share. These securities are beneficially own by ABPIIIKG. These securities are beneficially own by AEBPIII. by Alta BioPharma Management III, LLC /s/Farah Champsi, Director 2011-08-09 /s/ Edward Penhoet 2011-08-09 /s/ Farah Champsi 2011-08-09 /s/ Edward Hurwitz 2011-08-09 /s/ Farah Champsi, Director 2011-08-09 by Alta BioPharma Management Partners III, LLC /s/ Farah Champsi, Director 2011-08-09 /s/ Farah Champsi, Manager 2011-08-09